Arab finance: GlaxoSmithKline Egypt’s (GSK) consolidated net profits after tax and non-controlling interest soared 375.6% year on year (YoY) to EGP 735.38 million in 2022, compared to EGP 154.64 million, the firm’s income statement showed on April 4th.
Net revenues registered EGP 1.82 billion last year, up from EGP 1.01 billion in the year before.
Standalone net profits after tax surged 332.4% to EGP 718.18 million in 2022 from EGP 166.11 million in 2021.